Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Rubius Therapeutics Inc
(NQ:
RUBY
)
8.020
-3.160 (-28.26%)
Official Closing Price
Updated: 7:58 PM EST, Feb 25, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Rubius Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target
Today 7:00 EST
Cellarity, a life sciences company founded by Flagship Pioneering to develop a new method of drug discovery targeting the cell, announced today that it raised $123 million in Series B financing. The...
From
PR Newswire
Rubius Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
February 23, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
February 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
MGNX
Market News
ITOS
From
Benzinga
Earnings Scheduled For February 23, 2021
February 23, 2021
Companies Reporting Before The Bell • MFA Finl (NYSE:MFA) is likely to report quarterly earnings at $0.07 per share on ...
Tags
BMO
MATX
MTDR
From
Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ...
Tags
NUVA
LMAT
AERI
From
Benzinga
Rubius Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
February 18, 2021
From
GlobeNewswire News Releases
Rubius Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results
February 09, 2021
From
GlobeNewswire News Releases
Rubius Therapeutics to Participate in Guggenheim Healthcare Talks | 2021 Oncology Days
February 03, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO
January 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
VRTX
RUBY
RDHL
From
Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 28, 2021
On Thursday morning, 92 companies achieved new highs for the year. Interesting Highlights: Abbott ...
Tags
UI
SINO
CGC
From
Benzinga
The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO
January 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Biotech
ILMN
Earnings
From
Benzinga
98 Biggest Movers From Yesterday
January 28, 2021
Gainers Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) shares jumped 537.5% to close at $25.50 on Wednesday after the company priced ...
Tags
UONE
JAN
CVM
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 27, 2021
Gainers Sorrento Therapeutics (NASDAQ:SRNE) stock increased by 33.3% to $13.89 during Wednesday's regular session. ...
Tags
BZI/TFM
TTOO
Market News
From
Benzinga
RUBY Crosses Above Average Analyst Target
January 11, 2021
In recent trading, shares of Rubius Therapeutics Inc (RUBY) have crossed above the average analyst 12-month target price of $9.33, changing hands for $9.53/share. When a stock reaches the target an...
Tags
ETFs
From
ETF Channel
Rubius Therapeutics Provides Operational Update and Outlines 2021 Objectives at the 39th Annual J.P. Morgan Healthcare Conference
January 11, 2021
From
GlobeNewswire News Releases
Rubius Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021
From
GlobeNewswire News Releases
68 Biggest Movers From Yesterday
December 16, 2020
Gainers Prevail Therapeutics Inc. (NASDAQ: PRVL) shares jumped 82% to close at $22.75 on Tuesday after the company agreed to be ...
Tags
CREX
AVXL
METX
From
Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
December 15, 2020
Gainers Prevail Therapeutics Inc. (NASDAQ: PRVL) shares climbed 83.5% to $22.93 after the company agreed to be acquired by Eli ...
Tags
OPNT
Benzinga
VERU
From
Benzinga
Why Transdermal Drug Delivery Systems are Outweighing Advantages of Traditional Methods
December 15, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Why Transdermal Drug Delivery Systems are Outweighing Advantages of Traditional Methods
December 15, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
70 Biggest Movers From Yesterday
December 15, 2020
Gainers Arvinas, Inc. (NASDAQ: ARVN) shares climbed 95.1% to close at $58.38 on Monday after the company reported ...
Tags
BRPA
PRLD
GLSI
From
Benzinga
12 Healthcare Stocks Moving In Monday's After-Market Session
December 14, 2020
Gainers Opiant Pharmaceuticals (NASDAQ:OPNT) stock increased by 38.38% to $11.5 during Monday's after-market session. Opiant ...
Tags
CWBR
General
RUBY
From
Benzinga
Noteworthy Monday Option Activity: RUBY, LGND, FIXX
December 14, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Rubius Therapeutics Inc (RUBY), where a total volume of 9,633 contracts has been...
Tags
Stocks
From
Market News Video
12 Healthcare Stocks Moving In Monday's Intraday Session
December 14, 2020
Gainers Arvinas (NASDAQ:ARVN) shares rose 88.77% to $56.5 during Monday's regular session. The current volume of ...
Tags
Markets
TLGT
Intraday Update
From
Benzinga
52 Stocks Moving In Monday's Mid-Day Session
December 14, 2020
Gainers Arvinas, Inc. (NASDAQ: ARVN) shares jumped 103.4% to $60.87 after the company reported interim clinical data for its ...
Tags
ALGS
SYBX
XXII
From
Benzinga
72 Biggest Movers From Friday
December 14, 2020
Gainers AbCellera Biologics Inc. (NASDAQ: ABCL) shares jumped 194.5% to close at $58.90 after the company priced its IPO at $20 ...
Tags
DIS
SRG
SNOA
From
Benzinga
Rubius Therapeutics to Participate in Evercore ISI 3rd Annual HealthCONx Conference
November 30, 2020
From
GlobeNewswire News Releases
Rubius Therapeutics Breaks Above 200-Day Moving Average - Bullish for RUBY
November 23, 2020
In trading on Monday, shares of Rubius Therapeutics Inc (RUBY) crossed above their 200 day moving average of $5.66, changing hands as high as $5.83 per share. Rubius Therapeutics Inc shares are...
Tags
Stocks
From
Market News Video
Rubius Therapeutics to Participate in Jefferies Virtual London Healthcare Conference
November 10, 2020
From
GlobeNewswire News Releases
Implied VBK Analyst Target Price: $260
November 09, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.